v3.26.1
Statement of Changes in Shareholder’s Deficit - 3 months ended Mar. 31, 2026 - USD ($)
Ordinary shares
Class A
Ordinary shares
Class B
 [1]
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 767 $ 24,233 $ (76,662) $ (51,662)
Balance (in Shares) at Dec. 31, 2025 7,666,667      
Accretion for Class A ordinary shares to redemption amount 7,402,378 7,402,378
Sale of 403,146 Private Placement Units $ 40 4,031,420 4,031,460
Sale of 403,146 Private Placement Units (in Shares) 403,146      
Fair Value of Public Warrants at issuance 3,471,295 3,471,295
Fair Value of representative shares deferred until IPO $ 5 501,797 501,802
Fair Value of representative shares deferred until IPO (in Shares) 51,048      
Allocated value of transaction costs to other equity-classified instruments (69,294) (69,294)
Forfeiture of Founder Shares   $ (87) 87
Forfeiture of Founder Shares (in Shares) (860,205)      
Net income 1,102,874 1,102,874
Balance at Mar. 31, 2026 $ 45 $ 680 $ 557,160 $ 1,026,212 $ 1,584,097
Balance (in Shares) at Mar. 31, 2026      
[1] As of December 31, 2025, up to 1,000,000 Founder Shares were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised. On February 2, 2026, upon the partial exercise of the over-allotment option, 139,795 Founder Shares were no longer subject to forfeiture. On March 11, 2026, the Sponsor surrendered the remaining 860,205 Founder Shares to the Company for no consideration upon expiration of the unexercised portion of the over-allotment option.